Top Markets
Coin of the day
VectivBio Holding AG VectivBio Holding AG

VectivBio Holding AG

VECT
주식 순위 #14767
VectivBio Holding AG is a clinical-stage biopharmaceutical firm committed to... VectivBio Holding AG is a clinical-stage biopharmaceutical firm committed to identifying, developing, and commercializing treatments for severe rare medical conditions. The company's primary therapeutic focus is apraglutide, a prolonged-acting synthetic peptide analog of glucagon-like peptide-2. This compound is currently in a Phase III clinical trial for individuals with short bowel syndrome-intestinal failure (SBS-IF), and is also being evaluated in a Phase II clinical trial for SBS-IF patients with colon-in-continuity anatomy. Furthermore, apraglutide is undergoing a Phase II clinical study for patients experiencing steroid-refractory gastrointestinal acute graft-versus-host disease (aGvHD). Founded in 2019, VectivBio's corporate headquarters are situated in Basel, Switzerland.
주가
$16.85
마지막 동기화: 2023-07-07
시가총액
$393.50M
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
CH
거래 VectivBio Holding AG (VECT)

카테고리

VectivBio Holding AG (VECT)의 주가 이력
최고 종가: $16.72 (2023-07-01 기준)

최저 종가: $16.68 (2021-04-01 기준)
VectivBio Holding AG의 주가 이력 (2021 ~ 2026)
연간 주가 성과
연도 성과
2023 96.64%
2022 112.95%
2021 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$544.38 39.22%
US
$1.03K 45.21%
NL
$121.37 -11.93%
AU
$138.80 476.17%
US
$745.22 4.45%
CH